← Back to Search
Microbubble Contrast Agents: Targeted Ultrasound Imaging And Ultrasound-Assisted Drug-Delivery Applications
Published 2006 · Medicine
Download PDFAnalyze on Scholarcy
The use of microbubble contrast agents for general tissue delineation and perfusion enjoys steady interest in ultrasound imaging. Microbubbles as contrast materials require a small dosage and show excellent detection sensitivity. Targeting ligands on the surface of microbubbles permit the selective accumulation of these particles in the areas of interest, which show an up-regulated level of receptor molecules on vascular endothelium. Selective contrast imaging of inflammation, ischemia–reperfusion injury, angiogenesis, and thrombosis has been achieved in animal models. Ultrasound-assisted drug delivery and activation, performed by combining microbubble agent containing drug substances or coadministered with pharmaceutical agents (including plasmid DNA for transfection), has been achieved in multiple model systems in vitro and in vivo. Ultrasound and microbubbles-based targeted acceleration of the thrombolytic enzyme action already have reached clinical trials. Overall, microbubble targeting and ultrasound-assisted microbubble-based drug-delivery systems will offer a step toward the application of targeted personalized diagnostics and therapy.
This paper references
Liposomes containing modified cholesterol for organ targeting
P Ryan (1985)
Liposomes containing modified cholesterol for organ targeting. USA Patent
P Ryan (1985)
Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction.
R. Bekeredjian (2005)
Gene therapy strategies in prostate cancer.
I. Eder (2005)
Ultrasonic analysis of peptide- And antibody-targeted microbubble contrast agents for molecular imaging of α vβ 3-expressing cells
P. Dayton (2004)
Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis.
K. Tachibana (1995)
Targeted-Microbubble Binding Selectively to GPIIb IIIa Receptors of Platelet Thrombi
P. Schumann (2002)
Intravascular ultrasound molecular imaging of atheroma components in vivo.
A. Hamilton (2004)
New science-based endpoints to accelerate oncology drug development.
G. Kelloff (2005)
Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement.
N. G. Fisher (2002)
Targeting of ultrasound contrast material. An in vitro feasibility study.
A. Klibanov (1997)
Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle.
J. Song (2002)
Interaction with leukocytes: phospholipid-stabilized versus albumin-shell microbubbles.
H. Takeuchi (2004)
Detection of Coronary Artery Stenosis With Power Doppler Imaging
F. Villanueva (2001)
Ultrasound-Targeted Microbubble Destruction Can Repeatedly Direct Highly Specific Plasmid Expression to the Heart
R. Bekeredjian (2003)
Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine.
G. Weller (2005)
Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty.
T. Sakuma (2005)
Modulating Targeted Adhesion of an Ultrasound Contrast Agent to Dysfunctional Endothelium
G. Weller (2004)
Pharmaceutical Evaluation of Gas-Filled Microparticles as Gene Delivery System
S. Seemann (2004)
Ultrasound Imaging of Acute Cardiac Transplant Rejection With Microbubbles Targeted to Intercellular Adhesion Molecule-1
G. Weller (2003)
Detection of Individual Microbubbles of Ultrasound Contrast Agents: Imaging of Free-Floating and Targeted Bubbles
A. Klibanov (2004)
Delivery of biologically active substance to target sites in the body of patients. USA Patent no. 6258378
M Schneider (2001)
Targeted Microbubble Contrast ultrasound in declotting thrombosis
F Xie (2005)
Development of inherently echogenic liposomes as an ultrasonic contrast agent.
H. Alkan-Onyuksel (1996)
Preparation and characterization of hollow microcapsules for use as ultrasound contrast agents
P. Narayan (1999)
Further enhancement of fibrinolysis by ultrasound in the presence of echo contrast material. Circulation
K Tachibana (1993)
What is the relationship between flow and function in diabetic cardiomyopathy? A quantitative study using contrast echo and strain rate imaging
W. Moir (2004)
Interaction of diagnostic ultrasound with synthetic oligonucleotide‐labeled perfluorocarbon‐exposed sonicated dextrose albumin microbubbles.
T. Porter (1996)
Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging.
A. Klibanov (2005)
Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles.
J. Christiansen (2003)
Echocardiography of the aortic root.
R. Gramiak (1968)
Ultrasound Assessment of Inflammation and Renal Tissue Injury With Microbubbles Targeted to P-Selectin
J. Lindner (2001)
Gene Delivery Using Ultrasound Contrast Agents
E. Unger (2001)
Multi-targeting enhances adhesion of ultrasound contrast microbubbles to inflammatory endothelium
GE Weller (2003)
Real-time 3D echo increases feasibility of sequential echo follow-up in the real world - Reduction of test-retest variation of LV parameters
C. Jenkins (2003)
Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function.
M. Wang (2005)
THE STABILITY OF GAS BUBBLES IN LIQUID‐GAS SOLUTIONS *
C. Ward (1983)
Microbubbles in medical imaging: current applications and future directions
J. Lindner (2004)
Increase in Serum Amyloid A Evoked by Dietary Cholesterol Is Associated With Increased Atherosclerosis in Mice
Katherine E. Lewis (2004)
Molecular targeting of lymph nodes with L-selectin ligand-specific US contrast agent: a feasibility study in mice and dogs.
P. Hauff (2004)
Stimulierte akustische Emission mit dem Ultraschall-Kontrastmittel Levovist: Ein klinisch nutzbarer Kontrasteffekt mit leberspezifischen Eigenschaften
T. Albrecht (2000)
Physical and biochemical characterization of Albunex, a new ultrasound contrast agent consisting of air‐filled albumin microspheres suspended in a solution of human albumin
C. Christiansen (1994)
In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement.
S. Demos (1999)
Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres
G. Kindberg (2003)
Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.
D. Ellegala (2003)
Direct video-microscopic observation of the dynamic effects of medical ultrasound on ultrasound contrast microspheres.
A. Klibanov (1998)
Noninvasive Assessment of Angiogenesis by Ultrasound and Microbubbles Targeted to &agr;v-Integrins
H. Leong-Poi (2003)
Development of a novel microbubble agent for ultrasound-mediated targeted drug delivery
C W Lewis (2004)
Effectiveness of lipid microbubbles and Investigative Radiology
F Xie (2006)
Controlled vesicle deformation and lysis by single oscillating bubbles
P. Marmottant (2003)
Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experience.
K. Dittmar (2005)
Acoustic radiation force enhances targeted delivery of ultrasound contrast microbubbles: in vitro verification
J.J. Rychak (2005)
Vascular effects induced by combined 1-MHz ultrasound and microbubble contrast agent treatments in vivo.
J. Hwang (2005)
Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent.
E. Unger (1998)
Biodegradation and biocompatibility of PLA and PLGA microspheres.
Leukocyte-Targeted Myocardial Contrast Echocardiography Can Assess the Degree of Acute Allograft Rejection in a Rat Cardiac Transplantation Model
I. Kondo (2004)
Effectiveness of lipid microbubbles and ultrasound in declotting thrombosis.
Feng Xie (2005)
Prototype therapeutic ultrasound emitting catheter for accelerating thrombolysis.
K. Tachibana (1997)
Ultrasound-mediated therapies using bubble technology: an update
TO Matsunaga (2005)
High-speed optical observations of contrast agent destruction.
A. Bouakaz (2005)
Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles.
P. Dayton (1999)
Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models.
P. Hauff (2005)
Intracranial Clot Lysis With Intravenous Microbubbles and Transcranial Ultrasound in Swine
W. Culp (2004)
The effect of size on the acoustic response of polymer-shelled contrast agents.
Susannah H. Bloch (2005)
Microbubbles induce renal hemorrhage when exposed to diagnostic ultrasound in anesthetized rats.
J. Wible (2002)
BR1: A New Ultrasonographic Contrast Agent Based on Sulfur Hexafluoride-Filled Microbubbles
M. Schneider (1995)
Development of a novel microbubble agent for ultrasound-mediated targeted drug
CW Lewis (2004)
Targeting of ultrasound contrast material: selective imaging of microbubbles in vitro.
A. Klibanov (1998)
In Vivo Tracking of Stem Cells for Clinical Trials in Cardiovascular Disease
J. V. Frangioni (2004)
Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles.
J. Lindner (2000)
Noninvasive monitoring of stem cell transfer for muscle disorders
G. Walter (2004)
The Influence of Tiered Layers of Surface-Grafted Poly(ethylene glycol) on Receptor−Ligand-Mediated Adhesion between Phospholipid Monolayer-Stabilized Microbubbles and Coated Glass Beads
D. H. Kim (2000)
Ultrasound-triggered release of microbubble-associated material: site-targeted drug release and deposition
AL Klibanov (2004)
Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium: an intravital microscopy study in rats.
Y. Kono (2002)
Optical observation of lipid- and polymer-shelled ultrasound microbubble contrast agents
Susannah H. Bloch (2004)
Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents.
S. Huang (2002)
Enhancement of ultrasound-accelerated thrombolysis by echo contrast agents: dependence on microbubble structure.
K. Mizushige (1999)
Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta(3). Circulation
D B Ellegala (2003)
Ultrasound contrast microbubbles targeted to ICAM-1 detect acute heart transplant rejection
GER Weller (2002)
A method for radiation-force localized drug delivery using gas-filled lipospheres
M.J. Shortencarier (2004)
Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
J. L. Cohen (1998)
Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to &agr;v&bgr;3
D. Ellegala (2003)
[Stimulated acoustic emissions with the ultrasound contrast medium levovist: a clinically useful contrast effect with liver-specific properties].
T. Albrecht (2000)
Attachment of ligands onto the gas-filled microbubbles via PEG spacer arm and lipid residues anchored at the interface
AL Klibanov (1999)
Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow.
A. Takalkar (2004)
The use of a thrombus-specific ultrasound contrast agent to detect thrombus in arteriovenous fistulae.
E. Unger (2000)
Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound.
R. Price (1998)
Impact of polymer tether length on multiple ligand-receptor bond formation.
C. Jeppesen (2001)
Assessment of Endogenous and Therapeutic Arteriogenesis by Contrast Ultrasound Molecular Imaging of Integrin Expression
H. Leong-Poi (2005)
Gene-loading of targeted microbubbles does not adversely influence binding efficacy
S Champeneri (2006)
Further enhancement of fibrinolysis by ultrasound in the presence of echo contrast material
K Tachibana (1993)
Stimulated acoustic emission with the ultrasound contrast agent levovist: a clinically useful contrast effect with liver-specific properties. Rofo-Fortschr Rontg
T Albrecht (2000)
Optical and acoustical dynamics of microbubble contrast agents inside neutrophils.
P. Dayton (2001)
Noninvasive Imaging of Myocardial Reperfusion Injury Using Leukocyte-Targeted Contrast Echocardiography
J. Christiansen (2002)
Targeting and ultrasound imaging of microbubble-based contrast agents
A. Klibanov (2007)
Vascular‐targeted molecular imaging using functionalized polymerized vesicles
K. C. Li (2002)
Delivery of biologically active substance to target sites in the body of patients
M Schneider (2001)
Determination of Right Atrial and Right Ventricular Size by Two-Dimensional Echocardiography
W. Bommer (1979)
Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles. Demonstration and potential mechanisms.
T. Porter (1995)
Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells.
P. Dayton (2004)
Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells.
F. Villanueva (1998)
Enhanced binding of ultrasound contrast microbubbles targeted to P-selectin using a physiological capture ligand
JJ Rychak (2004)
This paper is referenced by
Effects of encapsulation elasticity on the stability of an encapsulated microbubble.
Amit Katiyar (2009)
Fluorous materials in microbubble engineering science and technology—Design and development of new bubble preparation and sizing technologies
Simona Rossi (2011)
Theranostic gas-generating nanoparticles for targeted ultrasound imaging and treatment of neuroblastoma.
Jangwook Lee (2016)
Analytical measurement of PEGylated molecules.
T. Cheng (2012)
Improved Techniques in Ultrasonic Molecular Imaging for Evaluating Response to Cancer Therapy
J. Streeter (2013)
Quantitative guidelines for the prediction of ultrasound contrast agent destruction during injection.
G. Threlfall (2013)
Bioinspired Nanostructured Surfaces for On-Demand Bubble Transportation.
Xin Tang (2018)
Toward ultrasound molecular imaging with phase-change contrast agents: an in vitro proof of principle.
P. Sheeran (2013)
Nano Air Seeds Trapped in Mesoporous Janus Nanoparticles Facilitate Cavitation and Enhance Ultrasound Imaging.
K. Tamarov (2017)
Fifty Years of the Best of Investigative Radiology.
Val Murray Runge (2015)
Development of an ultrasound triggered Nanomedicine-microbubble complex for chemo-photodynamic-gene therapy.
Yongho Jang (2020)
BR38, a New Ultrasound Blood Pool Agent
M. Schneider (2011)
Focused ultrasound and microbubbles for enhanced extravasation.
M. Boehmer (2010)
Aggregate enhanced trimodal porphyrin shell microbubbles for ultrasound, photoacoustic, and fluorescence imaging.
E. Huynh (2014)
Nano-Biotechnology for Biomedical and Diagnostic Research
E. Zahavy (2012)
Modeling of the acoustic response from contrast agent microbubbles near a rigid wall.
A. Doinikov (2009)
Effect of an elastic wall on the dynamics of an encapsulated microbubble: A simulation study.
Leila Aired (2013)
Enhancing Tumor Drug Distribution With Ultrasound-Triggered Nanobubbles.
Pinunta Nittayacharn (2019)
Acoustic responses of monodisperse lipid-encapsulated microbubble contrast agents produced by flow focusing.
M. Kaya (2010)
Contrast‐Enhanced Ultrasound in Urology
Rogier R. Wildeboer (2012)
Evaluation of 18F-labeled targeted perfluorocarbon-filled albumin microbubbles as a probe for microUS and microPET in tumor-bearing mice.
Ai-Ho Liao (2013)
Ultrasound-Targeted Microbubble Destruction Enhances the Antitumor Efficacy of Doxorubicin in a Mouse Hepatocellular Carcinoma Model.
Yongzheng Wu (2019)
Modelling and monitoring nonlinear acoustic phenomena in high-intensity focused ultrasound therapy
Edward R. Jackson (2015)
Pharmacodynamics of Streptavidin-Coated Cyanoacrylate Microbubbles Designed for Molecular Ultrasound Imaging
M. Palmowski (2008)
Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: Designing a new perspective in nanomedicine delivery
Alexander K Dhaliwal (2019)
Ultrasound activation of liposomes for enhanced ultrasound imaging and synergistic gas and sonodynamic cancer therapy
Xia-Hui Lin (2019)
Universal Equations for the Coalescence Probability and Long-Term Size Stability of Phospholipid-Coated Monodisperse Microbubbles Formed by Flow Focusing.
T. Segers (2017)
Ultrasound contrast agent loaded with nitric oxide as a theranostic microdevice
D. Grishenkov (2015)
Uniform scattering and attenuation of acoustically sorted ultrasound contrast agents: Modeling and experiments.
T. Segers (2016)
Porphyrin Microparticles for Biological and Biomedical Applications
E. Huynh (2015)
Magnetically Actuated Minimally Invasive Microbots for Biomedical Applications
H. Banerjee (2018)
Quantitative ultrasound in cancer imaging.
E. Feleppa (2011)See more